Publications (20) Publications de BORJA OTERO GARCIA-RAMOS

2024

  1. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis

    Menopause (New York, N.Y.), Vol. 31, Núm. 3, pp. 234-242

2023

  1. Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  2. Population-based survey on menopausal symptoms and treatment use

    Climacteric, Vol. 26, Núm. 1, pp. 47-54

  3. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after

    Quality of Life Research, Vol. 32, Núm. 4, pp. 989-1003

2022

  1. Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group

    Maturitas, Vol. 166, pp. 65-85

2021

  1. Factors that Influence Treatment Delay for Patients with Breast Cancer

    Annals of Surgical Oncology, Vol. 28, Núm. 7, pp. 3714-3721

  2. Health-related quality of life and resilience in peri- and postmenopausal women during Covid-19 confinement

    Maturitas, Vol. 144, pp. 4-10

  3. Utility of Intraoperative Fluorescence Imaging in Gynecologic Surgery: Systematic Review and Consensus Statement

    Annals of Surgical Oncology, Vol. 28, Núm. 6, pp. 3266-3278

2020

  1. Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia

    Maturitas, Vol. 137, pp. 57-62

  2. Response to “Should estrogen be used in the co-treatment of COVID-19 patients?”

    Maturitas

  3. The thromboembolic risk in covid-19 women under hormonal treatment group

    Maturitas

2018

  1. The sexual health approach in postmenopause: The five-minutes study

    Maturitas, Vol. 108, pp. 31-36

  2. What do TSECs provide in the menopausal hormone therapy?

    Gynecological Endocrinology, Vol. 34, Núm. 10, pp. 826-832

2016

  1. Psychometric attributes of the Cervantes short-form questionnaire for measuring health-related quality of life in menopausal women

    Maturitas, Vol. 84, pp. 55-62

2015

  1. Fertility preservation and breast cancer: A review

    ecancermedicalscience, Vol. 9

  2. Multidisciplinary approach to human papillomavirus infection

    Progresos de Obstetricia y Ginecologia

2014

  1. Quality of additional embryos transferred on pregnancy outcomes in IVF: Predictions using a mathematical approach

    Reproductive BioMedicine Online, Vol. 29, Núm. 2, pp. 200-208

  2. Tratamiento conservador del adenosarcoma mülleriano de cérvix uterino

    Progresos de Obstetricia y Ginecologia, Vol. 57, Núm. 2, pp. 83-87

2012

  1. Induction at 41 weeks increases the risk of caesarean section in a hospital with a low rate of caesarean sections

    Journal of Maternal-Fetal and Neonatal Medicine, Vol. 25, Núm. 9, pp. 1716-1718

2008

  1. Cáncer de vulva recidivante en una paciente con anemia de Fanconi

    Progresos en Obstetricia y Ginecologia, Vol. 51, Núm. 10, pp. 641-646